Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Experiments using FITC-phalloidin staining have revealed that BPC-157 is a potent stimulator of F-actin formation in fibroblasts [11]
Current batch B7392 99.75% Tested March 2026 View Certificate of Analysis Batch B7392 Customer Reviews No reviews yet Be the first to review this product
When combined (often referred to as BPC 157 TB 500 ), they are thought to provide both localized and systemic recovery support, making them a frequent topic of interest in discussions of athletic recovery, post-surgical healing, and chronic inflammation management
staggered titration Cycle driver GI tolerance sets the pace Tirzepatide Loading 2.5 5 7.5 10 12.5 mg (every 4 weeks) Frequency Once weekly Maintenance 15 mg weekly Route SubQ Cagrilintide Loading Start Week 9: 0.25 0.5 1.0 1.7 mg Frequency Once weekly Maintenance 2.4 mg weekly Route SubQ Weekly Schedule Example (Maintenance Phase) Monday Tirzepatide 15 mg (one site) + Cagrilintide 2.4 mg (different site) Tuesday No injections Wednesday No injections Thursday No injections Friday No injections Saturday No injections Sunday No injections Both compounds are once weekly
